Jeil Pharm (002620) - Total Liabilities

Latest as of September 2025: ₩400.33 Billion KRW ≈ $271.30 Million USD

Based on the latest financial reports, Jeil Pharm (002620) has total liabilities worth ₩400.33 Billion KRW (≈ $271.30 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Jeil Pharm to assess how effectively this company generates cash.

Jeil Pharm - Total Liabilities Trend (2011–2024)

This chart illustrates how Jeil Pharm's total liabilities have evolved over time, based on quarterly financial data. Check Jeil Pharm liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Jeil Pharm Competitors by Total Liabilities

The table below lists competitors of Jeil Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Bon Fame Co Ltd TWO:8433	Taiwan	NT$2.45 Billion
Austral Resources Australia Ltd AU:AR1	Australia	AU$197.46 Million
Gowa Makassar Tourism Develop JK:GMTD	Indonesia	Rp545.29 Billion
Fluent Inc NASDAQ:FLNT	USA	$54.47 Million
Parkit Enterprise Inc V:PKT	Canada	CA$153.26 Million
Digital Mediatama Maxima PT JK:DMMX	Indonesia	Rp177.23 Billion
Avgol Industries 1953 Ltd TA:AVGL	Israel	ILA256.81 Million
Dogusan Boru Sanayi ve Ticaret AS IS:DOGUB	Turkey	TL5.03 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Jeil Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Jeil Pharm (002620) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.15	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.27	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jeil Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jeil Pharm (2011–2024)

The table below shows the annual total liabilities of Jeil Pharm from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩453.04 Billion ≈ $307.02 Million	-5.19%
2023-12-31	₩477.81 Billion ≈ $323.81 Million	+7.16%
2022-12-31	₩445.88 Billion ≈ $302.17 Million	+13.71%
2021-12-31	₩392.11 Billion ≈ $265.73 Million	+1.03%
2020-12-31	₩388.11 Billion ≈ $263.02 Million	+6.79%
2019-12-31	₩363.44 Billion ≈ $246.30 Million	+9.96%
2018-12-31	₩330.51 Billion ≈ $223.98 Million	+1117.39%
2017-12-31	₩27.15 Billion ≈ $18.40 Million	-88.68%
2016-12-31	₩239.91 Billion ≈ $162.58 Million	+17.73%
2015-12-31	₩203.78 Billion ≈ $138.10 Million	+36.43%
2012-12-31	₩149.36 Billion ≈ $101.22 Million	-2.21%
2011-12-31	₩152.74 Billion ≈ $103.51 Million	--

About Jeil Pharm

KO:002620 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$93.63 Million

₩138.16 Billion KRW

Market Cap Rank

#19427 Global

#1071 in Korea

Share Price

₩9000.00

Change (1 day)

-1.10%

52-Week Range

₩7530.00 - ₩9280.00

All Time High

₩92178.44